• News
  • Law

Banyan Biomarkers licenses IP to Abbott

Banyan Biomarkers Inc., a company headquartered in Alachua, Fla. but with a growing presence in Carlsbad, has licensed its intellectual property related to traumatic brain injury (TBI) biomarkers to Abbott (NYSE: ABT) for assessment and verification. The terms of the agreement were not disclosed.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!